Lista de obras -

A prognostic gene expression signature in infratentorial ependymoma

artículo científico publicado en 2012

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study

artículo científico publicado en 2010

Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas

artículo científico publicado en 2015

Antiangiogenic therapy of brain tumors: the role of bevacizumab.

artículo científico publicado en 2014

Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology).

artículo científico publicado en 2013

Brain metastases: current management and new developments

artículo científico publicado en 2008

Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management

artículo científico publicado en 2017

Caveolin 1 expression independently predicts shorter survival in oligodendrogliomas

artículo científico publicado en 2009

Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.

artículo científico publicado en 2013

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.

artículo científico

Chemotherapy of anaplastic oligodendroglial tumours

artículo científico publicado en 2004

Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients

artículo científico publicado en 2014

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

artículo científico publicado en 2018

Controversies in management of low-grade gliomas in light of new data from clinical trials

artículo científico publicado en 2017

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

artículo científico publicado en 2017

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

artículo científico

Does intensification of chemotherapy in anaplastic oligodendrogliomas still have a role?

artículo científico publicado en 2017

Does valproic acid affect tumor growth and improve survival in glioblastomas?

artículo científico publicado en 2016

EANO guidelines for the diagnosis and treatment of meningiomas

artículo científico publicado en 2016

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

scientific article published on 08 December 2020

Ependymoma: current treatment options and a look to the future

artículo científico publicado en 2013

Ependymomas in adults

artículo científico publicado en 2010

Ependymomas of the adult: molecular biology and treatment

artículo científico publicado en 2008

Ependymomas, neuronal and mixed neuronal-glial tumors, dysembroblastic neuroepithelial tumors, pleomorphic xanthoastrocytomas, and pilocytic astrocytomas

artículo científico publicado en 2012

Epilepsy and brain tumors

artículo científico publicado en 2010

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.

artículo científico publicado en 2017

Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps

artículo científico publicado en 2015

Evidence-based management of adult patients with diffuse glioma - Authors' reply

artículo científico publicado en 2017

Extent of surgery in low-grade gliomas: an old question in a new context

artículo científico publicado en 2018

Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy ⬇️

artículo científico publicado el 1 de enero de 1982

Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system

artículo científico publicado en 2013

Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper

artículo científico

Imaging and clinical end points in brain metastases trials

artículo científico publicado en 2017

Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination

artículo científico publicado en 2009

Is there a Role for Bevacizumab in Non-Glial Tumors?

artículo científico

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.

artículo científico publicado en 2016

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.

artículo científico publicado en 2015

Leptomeningeal metastases: a RANO proposal for response criteria.

artículo científico publicado en 2016

Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials

artículo científico publicado en 2014

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications

Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept.

artículo científico publicado en 2016

MGMT promoter methylation in plasma of glioma patients receiving temozolomide

artículo científico publicado en 2014

Management of brain metastases according to molecular subtypes

artículo científico publicado en 2020

Molecularly based management of gliomas in clinical practice

artículo científico

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.

artículo científico publicado en 2015

Neuro-oncology: new insights and advances in treatment

scientific article published on January 2008

Neurologic complications of chemotherapy and other newer and experimental approaches

artículo científico

New developments in the treatment of malignant gliomas

artículo científico publicado en 2007

Pharmacologic therapies for malignant glioma: a guide for clinicians.

artículo científico publicado en 2014

Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis?

artículo científico publicado en 2016

Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.

artículo científico publicado en 2017

Radio- and chemotherapy of malignant gliomas. Pathological changes in the normal nervous tissue ⬇️

artículo científico publicado el 1 de enero de 1981

Rare glial tumors

artículo científico publicado en 2016

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

artículo científico publicado en 2016

Response assessment criteria for brain metastases: proposal from the RANO group.

artículo científico publicado en 2015

Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study

artículo científico publicado en 2016

Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study

artículo científico publicado en 2004

Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study

artículo científico publicado en 2013

Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments

artículo científico

Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas

artículo científico publicado el 1 de enero de 1992

Solitary brain metastasis as first manifestation of small-cell parotid gland carcinoma with high sensitivity to temozolomide therapy on basis of tumor O6-methylguanine-DNA-methyltransferase expression

artículo científico publicado en 2013

Targeted therapy in brain metastasis

artículo científico publicado en 2012

Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study

artículo científico publicado en 2015

The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors

artículo científico publicado en 2009

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

artículo científico publicado en 2016

Treatment of brain metastasis: current status and future directions

artículo científico publicado en 2016

Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012.

artículo científico publicado en 2012

Updates in the management of brain metastases.

artículo científico publicado en 2016

Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop.

artículo científico

Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001.

artículo científico publicado en 2017

Lista de obras de

A prognostic gene expression signature in infratentorial ependymoma

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study

Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas

Antiangiogenic therapy of brain tumors: the role of bevacizumab.

Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology).

Brain metastases: current management and new developments

Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management

Caveolin 1 expression independently predicts shorter survival in oligodendrogliomas

Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.

Chemotherapy of anaplastic oligodendroglial tumours

Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Controversies in management of low-grade gliomas in light of new data from clinical trials

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

Does intensification of chemotherapy in anaplastic oligodendrogliomas still have a role?

Does valproic acid affect tumor growth and improve survival in glioblastomas?

EANO guidelines for the diagnosis and treatment of meningiomas

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Ependymoma: current treatment options and a look to the future

Ependymomas in adults

Ependymomas of the adult: molecular biology and treatment

Ependymomas, neuronal and mixed neuronal-glial tumors, dysembroblastic neuroepithelial tumors, pleomorphic xanthoastrocytomas, and pilocytic astrocytomas

Epilepsy and brain tumors

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.

Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps

Evidence-based management of adult patients with diffuse glioma - Authors' reply

Extent of surgery in low-grade gliomas: an old question in a new context

Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy ⬇️

Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system

Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper

Imaging and clinical end points in brain metastases trials

Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination

Is there a Role for Bevacizumab in Non-Glial Tumors?

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.

Leptomeningeal metastases: a RANO proposal for response criteria.

Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications

Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept.

MGMT promoter methylation in plasma of glioma patients receiving temozolomide

Management of brain metastases according to molecular subtypes

Molecularly based management of gliomas in clinical practice

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.

Neuro-oncology: new insights and advances in treatment

Neurologic complications of chemotherapy and other newer and experimental approaches

New developments in the treatment of malignant gliomas

Pharmacologic therapies for malignant glioma: a guide for clinicians.

Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis?

Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.

Radio- and chemotherapy of malignant gliomas. Pathological changes in the normal nervous tissue ⬇️

Rare glial tumors

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Response assessment criteria for brain metastases: proposal from the RANO group.

Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study

Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study

Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study

Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments

Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas

Solitary brain metastasis as first manifestation of small-cell parotid gland carcinoma with high sensitivity to temozolomide therapy on basis of tumor O6-methylguanine-DNA-methyltransferase expression

Targeted therapy in brain metastasis

Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study

The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

Treatment of brain metastasis: current status and future directions

Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012.

Updates in the management of brain metastases.

Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop.

Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001.